MARKET

NVCR

NVCR

Novocure
NASDAQ
12.99
+0.49
+3.92%
After Hours: 12.99 0 0.00% 16:01 12/04 EST
OPEN
12.50
PREV CLOSE
12.50
HIGH
13.37
LOW
12.40
VOLUME
1.50M
TURNOVER
0
52 WEEK HIGH
120.03
52 WEEK LOW
10.87
MARKET CAP
1.39B
P/E (TTM)
-6.9794
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at NVCR last week (1127-1201)?
Weekly Report · 1d ago
Buy Rating on NovoCure Amid Strategic Restructuring and Promising Clinical Trials
TipRanks · 4d ago
Buy Rating on NovoCure Amid Strategic Reorganization and Growth Prospects
TipRanks · 6d ago
Maintaining Hold on NovoCure Amid Strategic Focus and Cost-Cutting Measures; Price Target Adjusted to $20
TipRanks · 11/28 16:35
Evercore ISI Is Pounding the Table on Rivian (RIVN) Stock With Outperform Rating
Investorplace · 11/28 16:35
FCEL Stock Alert: FuelCell Energy Announces AI Deal With IBM
Fuel cell energy company fuelcell energy (nasdaq:fcel) has announced a collaboration with ibm. The two companies will use foundation models to improve the performance of the company’s technology. Foundation models are a type of generative artificial intelligence (ai) to track the company's technology.
Investorplace · 11/28 16:15
Novocure Layoffs 2023: What to Know About the Latest NVCR Job Cuts
Investorplace · 11/28 15:51
Novocure: Current report
Press release · 11/28 14:00
More
About NVCR
NovoCure Limited is a global oncology company, which is principally engaged in the development, manufacturing and commercialization of Tumor Treating Fields (TTFields) devices, including Optune and Optune Lua, for the treatment of solid tumor cancers. TTFields are electric fields that exert physical forces to kill cancer cells via a variety of mechanisms. TTFields therapy has applicability across solid tumor types and lines of therapy. It is conducting phase three pivotal studies evaluating the use of TTFields in non-small cell lung cancer (NSCLC), ovarian cancer, brain metastases from NSCLC, and pancreatic cancer. The Company’s key priorities are to drive commercial adoption of Optune and Optune Lua, its commercial TTFields devices. The Company markets Optune in the United States, Germany, Japan and other countries. The Company markets Optune Lua in the United States and European Union. It also has a licence to market Optune in China, Hong Kong, Macau and Taiwan.

Webull offers Novocure Ltd stock information, including NASDAQ: NVCR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NVCR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NVCR stock methods without spending real money on the virtual paper trading platform.